跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG
Viatris Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 24, 2024
Approval ID
9a61f4794122368d
Company
Viatris Limited
Type
Standard
Approval Details
Approval Id
9a61f4794122368d
Drug Cima Aemps Name
ERIBULINA VIATRIS 0,44 MG/ML SOLUCION INYECTABLE EFG
Register Number
89659
Holder Company Name
Viatris Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.
Holder Company Detail Path
/organization/viatris-pharma-limited
Authorization Date
2024-06-24
Dosage Form
SOLUCIÓN INYECTABLE
Dose
0,44 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Viatris Limited
Company Detail Path
/organization/viatris-pharma-limited
Company Information
Pharmaceutical Company Name
VIATRIS PHARMA LIMITED
Country Name
Hong Kong, China
City Name
sha tin,country_hk
Address
Rm A7 8/F WAH WAI INDL BLDG
Active Ingredients
ERIBULINA
0,88 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 24, 2024
Approval ID
9a61f4794122368d
Type
Standard
Back to CIMA-AEMPS Approvals
